Role of Diet in Inflammatory Bowel Disease

Annals of Nutrition and Metabolism

Volumn 68, Issue 1, 2016, Pages 33-41

  Ruemmele, Frank M ^a  

^a Institut de Biologie Physico Chimique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARBOHYDRATE DIET; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CROHN DISEASE; DIET THERAPY; ENTERIC FEEDING; EXPERIMENTAL STUDY; FOOD COMPOSITION; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINE FUNCTION; META ANALYSIS (TOPIC); NONHUMAN; PALEOLITHIC DIET; PRIORITY JOURNAL; REMISSION; ADOLESCENT; ADULT; ANIMAL; CHILD; DYSBIOSIS; EVIDENCE BASED MEDICINE; IMMUNOLOGY; MICROBIOLOGY; PERSONALIZED MEDICINE; POPULATION DYNAMICS; WESTERN DIET;

ADOLESCENT; ADULT; ANIMALS; CHILD; DIET, WESTERN; DYSBIOSIS; ENTERAL NUTRITION; EVIDENCE-BASED MEDICINE; HEALTH TRANSITION; HUMANS; INFLAMMATORY BOWEL DISEASES; PRECISION MEDICINE; REMISSION INDUCTION;

EID: 84979010932     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000445392     Document Type: Article

References (63)

1. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM: Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17: 423-439.
2. Auvin S, Molinie F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, et al: Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr 2005; 41: 49-55.
3. Ruemmele FM: Pediatric inflammatory bowel diseases: coming of age. Curr Opin Gastroenterol 2010; 26: 332-336.
4. Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al: The ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014; 58: 795-806.
5. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124.
6. Nagalingam NA, Lynch SV: Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18: 968-984.
7. Pfeffer-Gik T, Levine A: Dietary clues to the pathogenesis of Crohn's disease. Dig Dis 2014; 32: 389-394.
8. Ruemmele FM, Garnier-Lengline H: Transforming growth factor and intestinal inflammation: the role of nutrition. Nestle Nutr Inst Workshop Ser 2013; 77: 91-98.
9. Amre DK, D'Souza S, Morgan K, Seidman G, Lambrette P, Grimard G, et al: Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. Am J Gastroenterol 2007; 102: 2016-2025.
10. Jantchou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonnel F: Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol 2010; 105: 2195-2201.
11. Shoda R, Matsueda K, Yamato S, Umeda N: Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996; 63: 741-745.
12. Hart AR, Luben R, Olsen A, Tjonneland A, Linseisen J, Nagel G, et al: Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion 2008; 77: 57-64.
13. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, et al: Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2014; 63: 776-784.
14. John S, Luben R, Shrestha SS, Welch A, Khaw KT, Hart AR: Dietary n-3 polyunsaturated fatty acids and the aetiology of ulcerative colitis: a UK prospective cohort study. Eur J Gastroenterol Hepatol 2010; 22: 602-606.
15. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, et al: A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013; 145: 970-977.
16. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA: Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 2008; 6: 121-131.
17. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al: Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-14696.
18. Nickerson KP, Homer CR, Kessler SP, Dixon LJ, Kabi A, Gordon IO, et al: The dietary polysaccharide maltodextrin promotes Salmonella survival and mucosal colonization in mice. PLoS One 2014; 9:e101789.
19. McDonald DE, Pethick DW, Mullan BP, Hampson DJ: Increasing viscosity of the intestinal contents alters small intestinal structure and intestinal growth, and stimulates proliferation of enterotoxigenic Escherichia coli in newly-weaned pigs. Br J Nutr 2001; 86: 487-498.
20. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al: High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-421.
21. Nickerson KP, McDonald C: Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One 2012; 7:e52132.
22. Moyana TN, Lalonde JM: Carrageenan-induced intestinal injury in the rat-a model for inflammatory bowel disease. Ann Clin Lab Sci 1990; 20: 420-426.
23. Swidsinski A, Ung V, Sydora BC, Loening-Baucke V, Doerffel Y, Verstraelen H, et al: Bacterial overgrowth and inflammation of small intestine after carboxymethyl cellulose ingestion in genetically susceptible mice. Inflamm Bowel Dis 2009; 15: 359-364.
24. Swidsinski A, Sydora BC, Doerffel Y, Loening-Baucke V, Vaneechoutte M, Lupicki M, et al: Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota. Inflamm Bowel Dis 2007; 13: 963-970.
25. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
26. Ruemmele FM, Roy CC, Levy E, Seidman EG: Nutrition as primary therapy in pediatric Crohn's disease: fact or fantasy? J Pediatr 2000; 136: 285-291.
27. Lochs H, Dejong C, Hammarqvist F, Hebuterne X, Leon-Sanz M, Schutz T, et al: ESPEN Guidelines on enteral nutrition: gastroenterology. Clin Nutr 2006; 25: 260-274.
28. Fell JM, Paintin M, Arnaud-Battandier F, Beattie RM, Hollis A, Kitching P, et al: Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000; 14: 281-289.
29. Heuschkel RB, Menache CC, Megerian JT, Baird AE: Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000; 31: 8-15.
30. Zachos M, Tondeur M, Griffiths AM: Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007;Cd000542.
31. Dziechciarz P, Horvath A, Shamir R, Szajewska H: Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007; 26: 795-806.
32. Seidman E: Semi-elemental (S-E) diet versus prednisone in pediatric Crohn's disease. Gastroenterology 1994; 104:A778.
33. Seidman E: Elemental diet versus prednisone as initial therapy in Crohn's disease: early and long term results. Gastroenterology 1991; 100:A250.
34. Sanderson IR, Udeen S, Davies PS, Savage MO, Walker-Smith JA: Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987; 62: 123-127.
35. Thomas AG, Taylor F, Miller V: Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr 1993; 17: 75-81.
36. Griffiths A: Elemental versus polymeric enteral nutrition as primary therapy for active Crohn's disease: a multi-centre pediatric randomized controlled trial. J Pediatr Gastroenterol Nutr 2000;31:S75.
37. Terrin G CR, Ambrosini A, et al: A semielemental diet (Pregomin) as primary therapy for inducing remission in children with active Crohn's disease. Ital J Pediatr 2002; 28: 401-405.
38. Borrelli O, Cordischi L, Cirulli M, Paganelli M, Labalestra V, Uccini S, et al: Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006; 4: 744-753.
39. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG: Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 30: 78-84.
40. Ludvigsson JF, Krantz M, Bodin L, Stenhammar L, Lindquist B: Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial. Acta Paediatr 2004; 93: 327-335.
41. Grogan JL, Casson DH, Terry A, Burdge GC, El-Matary W, Dalzell AM: Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up. Inflamm Bowel Dis 2012; 18: 246-253.
42. Day AS, Whitten KE, Sidler M, Lemberg DA: Systematic review: nutritional therapy in paediatric Crohn's disease. Aliment Pharmacol Ther 2008; 27: 293-307.
43. Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, et al: Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2010; 50(suppl 1):S14-S34.
44. Rubio A, Pigneur B, Garnier-Lengline H, Talbotec C, Schmitz J, Canioni D, et al: The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs. continuous enteral feeding. Aliment Pharmacol Ther 2011; 33: 1332-1339.
45. Buchanan E, Gaunt WW, Cardigan T, Garrick V, McGrogan P, Russell RK: The use of exclusive enteral nutrition for induction of remission in children with Crohn's disease demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther 2009; 30: 501-507.
46. Berni Canani R, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, et al: Shortand long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis 2006; 38: 381-387.
47. Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, Davies S, Murch S, Derkx B, et al: Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther 2004; 20: 167-172.
48. Beattie RM, Schiffrin EJ, Donnet-Hughes A, Huggett AC, Domizio P, MacDonald TT, et al: Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994; 8: 609-615.
49. Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, et al: Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Dig Liver Dis 2004; 36: 342-347.
50. Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al: Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis 2014; 8: 1179-1207.
51. Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS: Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 2006; 55: 356-361.
52. Yamamoto T, Nakahigashi M, Umegae S, Matsumoto K: Enteral nutrition for the maintenance of remission in Crohn's disease: a systematic review. Eur J Gastroenterol Hepatol 2010; 22: 1-8.
53. Lionetti P, Callegari ML, Ferrari S, Cavicchi MC, Pozzi E, de Martino M, et al: Enteral nutrition and microflora in pediatric Crohn's disease. JPEN J Parenter Enteral Nutr 2005; 29 (suppl 4):S173-S175; discussion S5-S8, S84-S88.
54. Shiga H, Kajiura T, Shinozaki J, Takagi S, Kinouchi Y, Takahashi S, et al: Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis 2012; 44: 736-742.
55. Obih C, Wahbeh G, Lee D, Braly K, Giefer M, Shaffer ML, et al: Specific carbohydrate diet for pediatric inflammatory bowel disease in clinical practice within an academic IBD center. Nutrition 2016; 32: 418-425.
56. Gibson PR, Shepherd SJ: Personal view: food for thought-western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis. Aliment Pharmacol Ther 2005; 21: 1399-1409.
57. Croagh C, Shepherd SJ, Berryman M, Muir JG, Gibson PR: Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. Inflamm Bowel Dis 2007; 13: 1522-1528.
58. Gearry RB, Irving PM, Barrett JS, Nathan DM, Shepherd SJ, Gibson PR: Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study. J Crohns Colitis 2009; 3: 8-14.
59. Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A: Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis 2014; 20: 1353-1360.
60. Eaton SB, Konner M: Paleolithic nutrition. A consideration of its nature and current implications. N Engl J Med 1985; 312: 283-289.
61. Ananthakrishnan AN, Cagan A, Gainer VS, Cai T, Cheng SC, Savova G, et al: Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis 2013; 19: 1921-1927.
62. Hou JK, Lee D, Lewis J: Diet and inflammatory bowel disease: review of patient-targeted recommendations. Clin Gastroenterol Hepatol 2014; 12: 1592-1600.
63. Molodecky NA, et al: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-52 .